Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MULTAQ for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 83 adverse event reports in the FDA FAERS database where MULTAQ was used for Atrial fibrillation.

Most Reported Side Effects for MULTAQ

Side Effect Reports % Deaths Hosp.
Atrial fibrillation 49 39.5% 0 8
Dyspnoea 12 9.7% 0 3
Blood creatinine increased 9 7.3% 0 1
Fatigue 8 6.5% 0 2
Drug ineffective 6 4.8% 0 2
Nausea 6 4.8% 1 2
Cough 5 4.0% 0 1
Dizziness 5 4.0% 0 2
Heart rate increased 5 4.0% 0 2
Malaise 5 4.0% 0 2
Renal impairment 5 4.0% 0 1

Other Indications for MULTAQ

Product used for unknown indication (17) Arrhythmia (5)

Other Drugs Used for Atrial fibrillation

RIVAROXABAN (52,584) DABIGATRAN ETEXILATE (20,492) APIXABAN (10,500) AMIODARONE (9,083) WARFARIN (8,680) EDOXABAN (3,855) ASPIRIN (2,993) DOFETILIDE (2,439) PRADAXA (2,325) METOPROLOL (1,542)

Related Pages

MULTAQ Full Profile All Atrial fibrillation Drugs MULTAQ Demographics MULTAQ Timeline